Renasant Bio is pioneering a new approach to treating autosomal dominant polycystic kidney disease (ADPKD) by developing small molecule correctors and potentiators that target the root cause of the disease, restoring the function of polycystin 1 and 2 (PC1/2) to halt disease progression
Renasant Bio is pioneering a new approach to treating autosomal dominant polycystic kidney disease (ADPKD) by developing small molecule correctors and potentiators that target the root cause of the disease, restoring the function of polycystin 1 and 2 (PC1/2) to halt disease progression.